MetaCap

Nexalin Technology Inc. Company Profile

NASDAQ: NXLHealth CareBiotechnology: Electromedical & Electrotherapeutic ApparatusUSD

3.63-0.48 (-11.68%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Nexalin Technology at a glance

Nexalin Technology Inc. (NASDAQ: NXL) is a Biotechnology: Electromedical & Electrotherapeutic Apparatus company in the Health Care sector headquartered in Houston, TX. Nexalin Technology is led by Mr. Mark White and employs about 8 people. The company's shares have traded publicly since 2022.

At a market capitalization of $3.0 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001527352, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does Nexalin Technology do?

Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health epidemic in the United States and China. The company offers Generation 1, an easy-to-administer medical device which utilizes bioelectronic medical technology to treat anxiety, insomnia, and depression without the need for drugs or psychotherapy; and Generation 2 and Generation 3 headset devices for the treatment of depression, substance use disorder, traumatic brain injury, post-traumatic stress disorder, opioid addiction, alcoholism, and chronic pain, as well as alzheimer's disease, and dementia. Nexalin Technology, Inc. is headquartered in Houston, Texas.

Business description based on the company's public filings.

Company information

Legal name
Nexalin Technology Inc.
Ticker
NASDAQ: NXL
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
CEO
Mr. Mark White
Employees
8
Headquarters
1776 Yorktown, Houston, TX, United States
Phone
832 260 0222
IPO year
2022
SEC CIK
0001527352

Companies similar to Nexalin Technology

NXL peer companies
CompanyPrice% ChgMarket capCompare
NUWENuwellis Inc.0.689+2.07%$2.51Mvs NXL
VBIOValion Bio Inc.2.14-3.17%$4.17Mvs NXL
NDRAENDRA Life Sciences Inc.5.46-7.93%$8.19Mvs NXL
IRIXIRIDEX Corporation0.89-0.89%$15.63Mvs NXL
ITOCiTonic Holdings Ltd Class A4.07+1.12%$29.74Mvs NXL
QTIQT Imaging Holdings Inc.2.68+3.08%$39.23Mvs NXL
POCIPrecision Optics Corporation Inc.4.58-1.82%$50.26Mvs NXL
OMOutset Medical Inc.4.05-0.98%$76.13Mvs NXL

Related